var data={"title":"Psychogenic purpura (Gardner-Diamond syndrome)","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Psychogenic purpura (Gardner-Diamond syndrome)</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/contributors\" class=\"contributor contributor_credentials\">Benjamin P Geisler, MD, MPH</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/contributors\" class=\"contributor contributor_credentials\">Lawrence LK Leung, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/contributors\" class=\"contributor contributor_credentials\">Jennifer S Tirnauer, MD</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Feb 10, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Psychogenic purpura (sometimes also referred to as Gardner-Diamond syndrome, autoerythrocyte sensitization, painful bruising syndrome) is a rare and poorly understood clinical presentation of unexplained painful ecchymotic lesions, mostly on the extremities <span class=\"nowrap\">and/or</span> the face. This disorder mainly occurs in Caucasian women with emotional stress or one or more concomitant mental illnesses. It has been speculated that this might be the disease entity responsible for historical descriptions of &quot;hysterical&quot; bleeding or religious stigmata.</p><p>The clinical, pathophysiologic, and diagnostic aspects of psychogenic purpura will be discussed here. The general approach to the patient with a bleeding diathesis is discussed separately. (See <a href=\"topic.htm?path=approach-to-the-adult-patient-with-a-bleeding-diathesis\" class=\"medical medical_review\">&quot;Approach to the adult patient with a bleeding diathesis&quot;</a> and <a href=\"topic.htm?path=approach-to-the-adult-with-unexplained-thrombocytopenia\" class=\"medical medical_review\">&quot;Approach to the adult with unexplained thrombocytopenia&quot;</a> and <a href=\"topic.htm?path=congenital-and-acquired-disorders-of-platelet-function\" class=\"medical medical_review\">&quot;Congenital and acquired disorders of platelet function&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">OVERVIEW</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The first publication concerning psychogenic purpura was by Gardner and Diamond in 1955 [<a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/1\" class=\"abstract_t\">1</a>]. Since that time, a number of reviews [<a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/2-7\" class=\"abstract_t\">2-7</a>] and case reports have been published, the vast majority in adult Caucasian women [<a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/8-37\" class=\"abstract_t\">8-37</a>], although this disorder has also been described in children, adolescents, and adult men [<a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/38-49\" class=\"abstract_t\">38-49</a>].</p><p>Disease episodes are associated with painful bruises on the extremities <span class=\"nowrap\">and/or</span> face; all systemic tests of the coagulation system are normal. Since psychogenic purpura occurs in the psychiatric patient population, factitious bleeding and deliberate self-induced mutilation or other trauma need to be ruled out.</p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h2\">Bleeding episodes</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>According to the patient, bruises occur either spontaneously or after trauma or surgery at other sites of the body. One patient, for example, had a wrist fracture and a subsequent carpal tunnel syndrome requiring intervention [<a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/4\" class=\"abstract_t\">4</a>]. This was accompanied by severe emotional disturbance; spontaneous bruises began three weeks later on the same arm and hand.</p><p>While some patients can describe the exact onset of purpura, others are unable to do so even after precise questioning. The patient usually has multiple small lesions that are purple in color, superficial in location, and may be associated with erythema and swelling.</p><p>In one documented case, a large area of &quot;bruising&quot; was noted over the patient's chest when told of hospital discharge that she considered premature. After physicians relented and granted additional hospital time, the &quot;lesions&quot; retreated within hours to a small central discoloration [<a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/50\" class=\"abstract_t\">50</a>].</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h2\">Concomitant psychiatric conditions</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Psychiatric conditions that have been associated with psychogenic purpura include depression, anxiety disorder, dissociative disorder, and multiple personality disorder, as well as conversion, histrionic, dependent, or borderline personality disorder. Many patients have sadomasochistic relationships, a history of verbal, physical, <span class=\"nowrap\">and/or</span> sexual abuse, and may have suffered one or more pregnancy losses or the loss of a child [<a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/51,52\" class=\"abstract_t\">51,52</a>].</p><p>In some patients, traits of a masochistic personality <span class=\"nowrap\">and/or</span> sleep disturbances and nightmares resembling the symptoms common in post-traumatic stress disorder may be observed. Most patients have been frequently hospitalized for various medical reasons and have had multiple surgeries. Malingering and factitious disorder, including Munchausen syndrome, need to be ruled out. (See <a href=\"#H28\" class=\"local\">'Psychiatric conditions and malingering'</a> below.)</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h2\">Religious stigmata</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The bleeding lesions in patients with psychogenic purpura have been likened to &quot;religious stigmata,&quot; a term that refers to bleeding <span class=\"nowrap\">and/or</span> sensations of pain in locations corresponding to the crucifixion wounds of Jesus Christ [<a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/53\" class=\"abstract_t\">53</a>]. These include wounds from nails in the hands and feet and from a lance in the side. Other reports include wounds to the forehead (&quot;crown of thorns&quot;), tears of blood or sweating blood [<a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/54\" class=\"abstract_t\">54</a>], wounds to the back as from whipping, or wounds to the shoulder as from bearing a cross.</p><p>Most cases of religious stigmata appear to have occurred in individuals of the Roman Catholic faith. Many are members of Catholic religious orders, and 90 percent are female. Well-known historical cases demonstrating religious stigmata might include Saint Catherine of Siena and Saint Francis of Assisi.</p><p>A striking similarity exists between religious stigmata cases in which bleeding occurred, and patients with psychogenic purpura. In both situations, the bleeding was otherwise unexplained, and the individuals were in a state of extreme emotional upset. In historical yet questionable reports of religious stigmata, the term &quot;religious ecstasy&quot; was used to describe the individual's condition, which some have regarded as an acute psychotic state. Other cases, however, are believed to be &quot;pious fraud&quot; [<a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/4,53,55,56\" class=\"abstract_t\">4,53,55,56</a>].</p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h1\">PATHOPHYSIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The pathophysiology of psychogenic purpura is not understood. Attempts to explain the phenomenon of psychogenic purpura include stress, an increase in local activity of tissue plasminogen activator (tPA), and a local autoimmune reaction to the patient's own erythrocytes.</p><p class=\"headingAnchor\" id=\"H7\"><span class=\"h2\">Response to stress</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>It is generally accepted that stress or &quot;distress&quot; (ie, an extreme response to one or more external stimuli causing a damaging pathophysiologic reaction in the host involving changes in behavior, physiology, and disease susceptibility) is associated with increased levels of endogenous glucocorticoids [<a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/53\" class=\"abstract_t\">53</a>]. Different types of stress (eg, fasting or heat shock) produce variable increases in glucocorticoids and catecholamines, and may alter hemostatic mechanisms, such as fibrinolysis [<a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/53,57-59\" class=\"abstract_t\">53,57-59</a>].</p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h2\">Increased fibrinolysis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Alterations in the fibrinolytic pathway, leading to fibrin degradation, have been found in some cases of psychogenic purpura [<a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/60-62\" class=\"abstract_t\">60-62</a>]. There is credible research showing that local (cutaneous) activity of tPA may be increased in psychogenic purpura [<a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/60\" class=\"abstract_t\">60</a>], leading to substantial amounts of local plasmin activity, rapid degradation of fibrin clots, and resultant bleeding.</p><p>In one report, for example, an increased intradermal tPA concentration could be shown in immunoassays of sites of psychogenic purpura; cutaneous fibrinolytic activity may be entirely inhibited by monoclonal antibodies directed against tPA [<a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/60\" class=\"abstract_t\">60</a>]. There is speculation that tPA release from endothelial cells is triggered by neuropeptides in the skin [<a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/53,60\" class=\"abstract_t\">53,60</a>].</p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h2\">Autoerythrocyte sensitization</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Autoerythrocyte sensitization refers to the mechanism that Gardner and Diamond originally ascribed to this clinical entity. Intradermal injection of autologous blood or washed red cells resulted in an ecchymotic lesion, whereas injection of control blood or saline did not [<a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/8,10,11\" class=\"abstract_t\">8,10,11</a>]. This finding has not been confirmed by others, and autoantibodies or cytotoxic T-lymphocytes directed against the individual's own erythrocytes have never been detected.</p><p class=\"headingAnchor\" id=\"H10\"><span class=\"h2\">Other mechanisms</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A number of other mechanisms and disorders have been postulated as underlying or exacerbating psychogenic purpura. However, because these have been reported infrequently, their relationship to psychogenic purpura may be completely fortuitous. These include:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Exacerbation by a copper-containing intrauterine device [<a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/63\" class=\"abstract_t\">63</a>]</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Coexisting coagulation or bleeding disorders (eg, immune thrombocytopenia (ITP), platelet function disorder, thrombocytosis) [<a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/42,64,65\" class=\"abstract_t\">42,64,65</a>]</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Presence of anticardiolipin antibodies or systemic lupus erythematosus [<a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/66,67\" class=\"abstract_t\">66,67</a>]</p><p/><p class=\"headingAnchor\" id=\"H11\"><span class=\"h1\">EVALUATION AND DIAGNOSIS</span></p><p class=\"headingAnchor\" id=\"H11814458\"><span class=\"h2\">Evaluation</span></p><p class=\"headingAnchor\" id=\"H12\"><span class=\"h3\">History</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The initial approach to any patient with a possible bleeding disorder consists of a complete bleeding history, including the use (or misuse) of medications that might be associated with bleeding (eg, antiplatelet agents, NSAIDs, steroids, selective serotonin reuptake inhibitors [SSRIs], and illicit drugs). It is also reasonable to determine whether the patient has access to medications with a high risk of bleeding (eg, <a href=\"topic.htm?path=warfarin-drug-information\" class=\"drug drug_general\">warfarin</a>, heparin products, direct thrombin or factor Xa inhibitors) prescribed for other patients, such as relatives. An occupational history might determine whether the patient has or had such access (eg, as a nurse or pharmacist).</p><p>A detailed psychiatric evaluation is of paramount importance if psychogenic purpura is suspected, with information concerning how the patient has responded to major stressful events in his or her life (eg, fetal losses, death in the family, divorce, loss of income).</p><p class=\"headingAnchor\" id=\"H13\"><span class=\"h3\">Typical episode</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The typical history is that, often following trauma or surgery, an episode is heralded by a burning, stinging, or painful sensation in an extremity or the face, followed a few hours later by local warmth, puffiness, erythema, and pruritus [<a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/68\" class=\"abstract_t\">68</a>]. The pain usually subsides when ecchymotic lesions finally appear. Pain and swelling may be sufficiently severe to cause immobilization of the affected extremity.</p><p class=\"headingAnchor\" id=\"H14\"><span class=\"h3\">Physical examination</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The locations of skin lesions, if present, need to be carefully noted, with attention to matching up the painful areas with the sites of actual skin bleeding. The patient must be examined thoroughly for scars and signs of other wounds, as well as for venipuncture sites, which may mean that the patient has drawn his or her own blood to be added to body fluids to simulate bleeding. (See <a href=\"topic.htm?path=approach-to-the-adult-patient-with-a-bleeding-diathesis\" class=\"medical medical_review\">&quot;Approach to the adult patient with a bleeding diathesis&quot;</a>.)</p><p>Some patients with psychogenic purpura report pain in the involved region that may not exactly match the location of the ecchymoses. All peripheral pulses are usually palpable and not diminished in amplitude. In some cases skin folds and hair follicles may be spared (<a href=\"image.htm?imageKey=HEME%2F109195\" class=\"graphic graphic_picture graphicRef109195 \">picture 1</a>) [<a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/17\" class=\"abstract_t\">17</a>].</p><p>On occasion, the skin lesions and associated redness and swelling may be severe enough to mimic cellulitis [<a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/69\" class=\"abstract_t\">69</a>] or an acute compartment syndrome [<a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/70\" class=\"abstract_t\">70</a>]. The rapid resolution of an involved area in one documented case suggests that some of these skin lesions may be vasoactive in nature, rather than being secondary to bleeding into the skin (<a href=\"image.htm?imageKey=HEME%2F105524\" class=\"graphic graphic_picture graphicRef105524 \">picture 2</a>) [<a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/50\" class=\"abstract_t\">50</a>].</p><p class=\"headingAnchor\" id=\"H15\"><span class=\"h3\">Laboratory testing</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In all reported cases of psychogenic purpura, the systemic prothrombin time or international normalized ratio <span class=\"nowrap\">(PT/INR),</span> activated partial thromboplastin time (aPTT), and complete blood count have been normal. Therefore, we suggest that in patients with bleeding confined to the skin, only the standard tests need to be performed (eg, PT, aPTT, complete blood count with platelet count). A serum creatinine can be checked to rule out platelet dysfunction due to uremia.</p><p>Additional tests that may be warranted include:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Evaluation for von Willebrand disease (see <a href=\"topic.htm?path=clinical-presentation-and-diagnosis-of-von-willebrand-disease\" class=\"medical medical_review\">&quot;Clinical presentation and diagnosis of von Willebrand disease&quot;</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The PFA-100 test to rule out a platelet function disorder (see <a href=\"topic.htm?path=approach-to-the-adult-patient-with-a-bleeding-diathesis#H14\" class=\"medical medical_review\">&quot;Approach to the adult patient with a bleeding diathesis&quot;, section on 'The Platelet Function Analyzer'</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A test to rule out presence of the antiphospholipid syndrome (see <a href=\"topic.htm?path=diagnosis-of-antiphospholipid-syndrome\" class=\"medical medical_review\">&quot;Diagnosis of antiphospholipid syndrome&quot;</a>)</p><p/><p>Workup for <strong>all</strong> of the conditions that might be associated with skin bleeding in a patient with a normal <span class=\"nowrap\">PT/INR,</span> aPTT, and complete blood count is time-consuming and expensive, and is <strong>not recommended</strong>. Such extensive testing is warranted only if recurring bleeding episodes have been carefully documented and the patient's history, family history, laboratory tests, and bleeding pattern are typical for one or more of these disorders. (See <a href=\"topic.htm?path=approach-to-the-adult-patient-with-a-bleeding-diathesis#H23\" class=\"medical medical_review\">&quot;Approach to the adult patient with a bleeding diathesis&quot;, section on 'Normal PT and aPTT'</a>.)</p><p>Given that patients may present with a recent history of bleeding at sites other than the skin, samples of urine, vomitus, or stool should be evaluated to determine whether or not blood is actually present in the specimen. If present, it is helpful to determine the following:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Whether the blood is of human origin</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Whether the blood comes from the patient</p><p/><p>This may be established by testing for red cell antigens (eg, non-primate red cells do not carry the Rh antigen) or by direct microscopic examination for the presence of nucleated red cells, as might be the case if the blood arose from avian sources (ie, chicken blood).</p><p>The autoerythrocyte sensitization test has never been critically analyzed or standardized and is not available in clinical laboratories [<a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/1\" class=\"abstract_t\">1</a>]. In addition, the sensitivity and specificity of this test for the diagnosis of psychogenic purpura are completely unknown. This test should not be attempted.</p><p>Although a prolonged bleeding time has been observed in some patients with possible psychogenic purpura [<a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/8\" class=\"abstract_t\">8</a>], this may have been related to the ingestion of <a href=\"topic.htm?path=aspirin-drug-information\" class=\"drug drug_general\">aspirin</a> or other medications with antiplatelet activity. Thus, measuring the bleeding time will most likely not be diagnostically helpful. In addition, some clinical coagulation laboratories no longer perform the bleeding time test for any condition because of problems with test reproducibility as well as the inability to correlate test results with clinical bleeding tendencies.</p><p class=\"headingAnchor\" id=\"H11814506\"><span class=\"h2\">Diagnosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The diagnosis of psychogenic purpura requires the presence of purpura or bleeding in a patient with normal PT, aPTT, and complete blood count, while other causes of bleeding and psychiatric conditions must be eliminated as possible causes of the clinical findings. A limited number of diagnostic studies guided by the clinical setting are used to rule out other likely conditions. (See <a href=\"#H15\" class=\"local\">'Laboratory testing'</a> above.)</p><p class=\"headingAnchor\" id=\"H18\"><span class=\"h1\">DIFFERENTIAL DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Before a diagnosis of psychogenic purpura is made, a number of other conditions should be ruled out based on clinical history and further diagnostic testing if indicated. In all of the published case reports of psychogenic purpura, the prothrombin time <span class=\"nowrap\">(PT/INR),</span> activated partial thromboplastin time (aPTT), and platelet counts have been normal. Thus, the differential diagnosis includes conditions associated with bleeding and normal results for these three tests. (See <a href=\"topic.htm?path=approach-to-the-adult-patient-with-a-bleeding-diathesis#H23\" class=\"medical medical_review\">&quot;Approach to the adult patient with a bleeding diathesis&quot;, section on 'Normal PT and aPTT'</a>.)</p><p>Laboratory evaluation for other conditions associated with bleeding or purpura in a patient with a normal PT, aPTT, and complete blood count is warranted only if there is documentation of recurring bleeding episodes and the patient&rsquo;s history, family history, laboratory tests, and bleeding pattern are typical for one or more of these disorders.</p><p>Patients with psychogenic purpura may be difficult to deal with. In particular, they may give partly false or incomplete histories and be noncompliant. It is unclear whether negative countertransference (ie, redirection of a treating clinician&rsquo;s negative feelings towards a patient) may be an indicator for psychogenic purpura. A multispecialty approach involving a hematologist, a psychiatrist, and, in the case of suspected vascular purpura, a rheumatologist may be required in order to rule out relevant underlying disorders.</p><p class=\"headingAnchor\" id=\"H19\"><span class=\"h2\">Inherited bleeding disorders</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In the inherited bleeding disorders, an acute onset in adulthood with the first hemorrhagic manifestation occurring at multiple cutaneous sites is extremely uncommon.</p><p class=\"headingAnchor\" id=\"H20\"><span class=\"h3\">von Willebrand disease</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In von Willebrand disease (VWD), normal coagulation parameters and late onset during adolescence are frequently observed [<a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/71\" class=\"abstract_t\">71</a>]. In such patients, the intake of <a href=\"topic.htm?path=aspirin-drug-information\" class=\"drug drug_general\">aspirin</a> or nonsteroidal anti-inflammatory drugs (NSAIDs) can lead to bleeding that would not have occurred otherwise. The diagnosis of mild VWD may be difficult to make, and may require serial testing. (See <a href=\"topic.htm?path=clinical-presentation-and-diagnosis-of-von-willebrand-disease\" class=\"medical medical_review\">&quot;Clinical presentation and diagnosis of von Willebrand disease&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H21\"><span class=\"h3\">Factor XIII deficiency</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Congenital (or acquired) factor XIII deficiency is associated with normal PT and aPTT. The most commonly reported clinical symptoms include excessive bleeding after invasive procedures, umbilical cord, intracranial, muscle and joint bleeding, as well as recurrent miscarriages and impaired wound healing. Hence, this disorder is not likely to be confused with psychogenic purpura. (See <a href=\"topic.htm?path=acquired-inhibitors-of-coagulation#H30\" class=\"medical medical_review\">&quot;Acquired inhibitors of coagulation&quot;, section on 'Factor XIII inhibitors'</a> and <a href=\"topic.htm?path=rare-inherited-coagulation-disorders#H4349864\" class=\"medical medical_review\">&quot;Rare inherited coagulation disorders&quot;, section on 'Factor XIII deficiency (F13D)'</a>.)</p><p class=\"headingAnchor\" id=\"H22\"><span class=\"h2\">Vascular purpuras</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The vascular purpuras include severe vitamin C deficiency, structural vascular abnormalities (eg, hereditary hemorrhagic telangiectasia), hereditary disorders of connective tissue (eg, Ehlers-Danlos syndrome, osteogenesis imperfecta), small vessel vasculitis, and purpura associated with the presence of paraproteins or amyloid involvement of cutaneous vessels.</p><p>In most cases, routine history, physical examination, and laboratory testing will be sufficient to suspect these diagnoses. (See <a href=\"topic.htm?path=overview-of-water-soluble-vitamins#H54\" class=\"medical medical_review\">&quot;Overview of water-soluble vitamins&quot;, section on 'Vitamin C (ascorbic acid)'</a> and <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-hereditary-hemorrhagic-telangiectasia-osler-weber-rendu-syndrome\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome)&quot;</a> and <a href=\"topic.htm?path=joint-hypermobility-syndrome\" class=\"medical medical_review\">&quot;Joint hypermobility syndrome&quot;</a> and <a href=\"topic.htm?path=osteogenesis-imperfecta-clinical-features-and-diagnosis\" class=\"medical medical_review\">&quot;Osteogenesis imperfecta: Clinical features and diagnosis&quot;</a> and <a href=\"topic.htm?path=overview-of-amyloidosis#H18\" class=\"medical medical_review\">&quot;Overview of amyloidosis&quot;, section on 'Skin manifestations'</a>.)</p><p>If a systemic vasculitis is suspected, an autoantibody screen including anti-nuclear antibodies (ANA) and anti-mitochondrial antibodies (AMA) as well as a skin biopsy may be useful.</p><p class=\"headingAnchor\" id=\"H23\"><span class=\"h2\">Antiphospholipid syndrome</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Occasionally, patients with the antiphospholipid syndrome may present with painful cutaneous lesions showing necrosis, infarctions, <span class=\"nowrap\">and/or</span> ulcerations. (See <a href=\"topic.htm?path=clinical-manifestations-of-antiphospholipid-syndrome#H30\" class=\"medical medical_review\">&quot;Clinical manifestations of antiphospholipid syndrome&quot;, section on 'Cutaneous manifestations'</a>.)</p><p class=\"headingAnchor\" id=\"H24\"><span class=\"h2\">Drug intake</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A number of medications may be associated with bleeding, especially in patients with a prior psychiatric history.</p><p class=\"headingAnchor\" id=\"H22925964\"><span class=\"h3\">Antiplatelet agents and anticoagulants</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Antiplatelet agents (eg, <a href=\"topic.htm?path=aspirin-drug-information\" class=\"drug drug_general\">aspirin</a>, nonsteroidal antiinflammatory drugs, P2Y<sub>12</sub> receptor blockers, or GP <span class=\"nowrap\">IIb/IIIa</span> inhibitors) may be prescribed by another clinician, prescribed for a family member, obtained surreptitiously or purchased without a prescription. Bleeding severity depends on the amount of the agent taken, and may be greater when two or more agents are combined [<a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/72\" class=\"abstract_t\">72</a>]. The extent of evaluation needed for the presence of these agents (eg, via acetylsalicylic acid level) should be determined on a case-by-case basis. (See <a href=\"topic.htm?path=approach-to-the-adult-patient-with-a-bleeding-diathesis#H4\" class=\"medical medical_review\">&quot;Approach to the adult patient with a bleeding diathesis&quot;, section on 'Medication use'</a>.)</p><p>Some anticoagulants (eg, vitamin K antagonists, heparin products, direct thrombin inhibitors, or factor Xa inhibitors) can cause clinical bleeding without prolonging both the <span class=\"nowrap\">PT/INR</span> and aPTT tests. The extent of evaluation for the presence of these drugs depends on the clinical situation. The appropriate coagulation tests to detect the presence of these agents are discussed separately. (See <a href=\"topic.htm?path=warfarin-and-other-vkas-dosing-and-adverse-effects\" class=\"medical medical_review\">&quot;Warfarin and other VKAs: Dosing and adverse effects&quot;</a> and <a href=\"topic.htm?path=heparin-and-lmw-heparin-dosing-and-adverse-effects\" class=\"medical medical_review\">&quot;Heparin and LMW heparin: Dosing and adverse effects&quot;</a> and <a href=\"topic.htm?path=direct-oral-anticoagulants-and-parenteral-direct-thrombin-inhibitors-dosing-and-adverse-effects\" class=\"medical medical_review\">&quot;Direct oral anticoagulants and parenteral direct thrombin inhibitors: Dosing and adverse effects&quot;</a>.)</p><p><a href=\"topic.htm?path=warfarin-drug-information\" class=\"drug drug_general\">Warfarin</a> and heparin products used at therapeutic doses typically prolong the PT and aPTT, respectively. As long as PT and aPTT testing is done on the same day as the bleeding episode occurs, the presence of these drugs will be apparent.</p><p class=\"headingAnchor\" id=\"H25\"><span class=\"h3\">SSRIs</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Bleeding occurring during treatment with selective serotonin reuptake inhibitors (SSRIs) might be related to inhibition of platelet aggregation due to the effect of these agents on decreasing intraplatelet serotonin concentrations [<a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/73\" class=\"abstract_t\">73</a>]. As an example, the SSRI <a href=\"topic.htm?path=paroxetine-drug-information\" class=\"drug drug_general\">paroxetine</a> inhibits platelet plug formation under shear stress and decreases platelet responsiveness to thrombin receptor-activating peptide [<a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/74\" class=\"abstract_t\">74</a>]. NSAID or <a href=\"topic.htm?path=warfarin-drug-information\" class=\"drug drug_general\">warfarin</a> intake may aggravate these SSRI-related adverse events [<a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/72,75-77\" class=\"abstract_t\">72,75-77</a>].</p><p>SSRI-treated patients may present with ecchymoses or mucosal bleeding, including gastrointestinal and vaginal bleeding and epistaxis, often with a concomitant increase in bleeding time. When the SSRIs are discontinued, platelet function typically normalizes and hemorrhage ceases [<a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/74\" class=\"abstract_t\">74</a>]. In one documented case, ecchymoses appearing after SSRI treatment were successfully treated with vitamin C [<a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/78\" class=\"abstract_t\">78</a>]. (See <a href=\"topic.htm?path=selective-serotonin-reuptake-inhibitors-pharmacology-administration-and-side-effects#H12543449\" class=\"medical medical_review\">&quot;Selective serotonin reuptake inhibitors: Pharmacology, administration, and side effects&quot;, section on 'Bleeding'</a>.)</p><p class=\"headingAnchor\" id=\"H26\"><span class=\"h3\">Illicit drugs</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Subarachnoid hemorrhage after 3,4-MethyleneDioxyMethAmphetamine (MDMA, &quot;Ecstasy&quot;) abuse has been reported in a single subject [<a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/79\" class=\"abstract_t\">79</a>]; little is otherwise known about bleeding complications following use of this drug.</p><p class=\"headingAnchor\" id=\"H27\"><span class=\"h3\">Steroids</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Some cases of suspected psychogenic purpura may be due to steroid-induced purpura, which typically affects the sun-exposed areas of the dorsum of the hand and forearm and is not accompanied by palpable swelling or pain. (See <a href=\"topic.htm?path=major-side-effects-of-systemic-glucocorticoids#H6\" class=\"medical medical_review\">&quot;Major side effects of systemic glucocorticoids&quot;, section on 'Dermatologic effects and appearance'</a>.)</p><p class=\"headingAnchor\" id=\"H28\"><span class=\"h2\">Psychiatric conditions and malingering</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Some cases have been reported in which factitious purpura and psychogenic purpura were the main differential diagnoses [<a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/80,81\" class=\"abstract_t\">80,81</a>]. Self-induced mutilation can occur in impulse disorders, malingering, and factitious disorders, including Munchausen syndrome.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In impulse disorders, patients fail to resist impulses to scratch themselves.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In malingering, illness is feigned or exaggerated for an external incentive.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In factitious disorder, the sufferer intentionally causes the abnormality in order to gain attention, sympathy, treatment, and comfort from medical personnel [<a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/82\" class=\"abstract_t\">82</a>].</p><p/><p>The hemorrhagic presenting profile of patients with factitious bleeding has been termed &quot;hemorrhagica histrionica&quot; [<a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/83\" class=\"abstract_t\">83</a>], which reminds one of the histrionic personality disorder, one of the concomitant mental illnesses that may accompany psychogenic purpura. (See <a href=\"topic.htm?path=factitious-disorder-imposed-on-self-munchausen-syndrome\" class=\"medical medical_review\">&quot;Factitious disorder imposed on self (Munchausen syndrome)&quot;</a> and <a href=\"topic.htm?path=overview-of-personality-disorders#H5\" class=\"medical medical_review\">&quot;Overview of personality disorders&quot;, section on 'Clinical manifestations'</a>.)</p><p class=\"headingAnchor\" id=\"H29\"><span class=\"h3\">Munchausen syndrome</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The most extreme form of the factitious disorders is Munchausen syndrome, in which the patient travels extensively and seeks multiple invasive procedures. The disorder is named after Baron M&uuml;nchhausen, a real person who was portrayed in fiction as a famous teller of tall tales. The prevalence of Munchausen syndrome is relatively low; it is more frequent in men, health care professionals and their relatives, and in those suffering from bipolar disorders. (See <a href=\"topic.htm?path=factitious-disorder-imposed-on-self-munchausen-syndrome\" class=\"medical medical_review\">&quot;Factitious disorder imposed on self (Munchausen syndrome)&quot;</a>.)</p><p>In Munchausen syndrome by proxy, bleeding in a child may be induced by a parent or relative and is an insidious form of child abuse [<a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/84\" class=\"abstract_t\">84</a>]. (See <a href=\"topic.htm?path=medical-child-abuse-munchausen-syndrome-by-proxy\" class=\"medical medical_review\">&quot;Medical child abuse (Munchausen syndrome by proxy)&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H11814333\"><span class=\"h1\">TREATMENT</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>If psychogenic purpura is the final diagnosis, we suggest referral for psychiatric treatment as the only reasonable therapeutic option. Involvement of family members may also be advisable. Such treatment may result in a favorable outcome, especially in children, adolescents, and those with only a short personal history of this disorder [<a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/39-41,43\" class=\"abstract_t\">39-41,43</a>].</p><p class=\"headingAnchor\" id=\"H30\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Psychogenic purpura is a rare condition with a reasonably stereotyped clinical presentation. (See <a href=\"#H13\" class=\"local\">'Typical episode'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Routine coagulation tests are normal and, although the pathophysiology of the disorder is uncertain, an abnormal psychiatric history is virtually always present. (See <a href=\"#H6\" class=\"local\">'Pathophysiology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>We suggest that, in patients with a single episode of bleeding confined to the skin, only the standard tests need to be performed (eg, prothrombin time (PT), activated partial thromboplastin time (aPTT), complete blood count (CBC) including examination of the peripheral blood smear) plus evaluation for von Willebrand disease. Additional tests that might be considered include the PFA-100 test to rule out a platelet function disorder and a test to rule out presence of the antiphospholipid syndrome (see <a href=\"#H11814458\" class=\"local\">'Evaluation'</a> above).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The diagnosis of psychogenic purpura requires the presence of purpura or bleeding (<a href=\"image.htm?imageKey=HEME%2F105524\" class=\"graphic graphic_picture graphicRef105524 \">picture 2</a> and <a href=\"image.htm?imageKey=HEME%2F109195\" class=\"graphic graphic_picture graphicRef109195 \">picture 1</a>) in a patient with normal <span class=\"nowrap\">PT/INR,</span> aPTT, CBC, and creatinine. Other causes of bleeding, and malingering or factitious disorders, must be eliminated as possible causes of the clinical findings. A limited number of diagnostic studies guided by the clinical setting are used to rule out other likely conditions. (See <a href=\"#H11814506\" class=\"local\">'Diagnosis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Patients with psychogenic purpura may be difficult to deal with. In particular, they may give partly false or incomplete histories and be noncompliant. A multispecialty approach involving a hematologist, a psychiatrist, and, in the case of suspected vascular purpura, a rheumatologist may be required in order to evaluate the presence of the relevant underlying disorders. (See <a href=\"#H18\" class=\"local\">'Differential diagnosis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>If psychogenic purpura is the final diagnosis, we suggest referral for psychiatric treatment as the only reasonable therapeutic option (<a href=\"grade.htm?i=6\" class=\"grade\">Grade 2C</a>). (See <a href=\"#H11814333\" class=\"local\">'Treatment'</a> above.)</p><p/><p class=\"headingAnchor\" id=\"H1685165647\"><span class=\"h1\">ACKNOWLEDGMENT</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>UpToDate would like to acknowledge Bruce J Dezube, MD who contributed to earlier versions of this topic review.</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/1\" class=\"nounderline abstract_t\">GARDNER FH, DIAMOND LK. Autoerythrocyte sensitization; a form of purpura producing painful bruising following autosensitization to red blood cells in certain women. Blood 1955; 10:675.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/2\" class=\"nounderline abstract_t\">Ratnoff OD. Psychogenic purpura (autoerythrocyte sensitization): an unsolved dilemma. Am J Med 1989; 87:16N.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/3\" class=\"nounderline abstract_t\">Ratnoff OD, Agle DP. Psychogenic purpura: a re-evaluation of the syndrome of autoerythrocyte sensitization. Medicine (Baltimore) 1968; 47:475.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/4\" class=\"nounderline abstract_t\">Ratnoff OD. The psychogenic purpuras: a review of autoerythrocyte sensitization, autosensitization to DNA, &quot;hysterical&quot; and factitial bleeding, and the religious stigmata. Semin Hematol 1980; 17:192.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/5\" class=\"nounderline abstract_t\">Uthman IW, Moukarbel GV, Salman SM, et al. Autoerythrocyte sensitization (Gardner-Diamond) syndrome. Eur J Haematol 2000; 65:144.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/6\" class=\"nounderline abstract_t\">Ivanov OL, Lvov AN, Michenko AV, et al. Autoerythrocyte sensitization syndrome (Gardner-Diamond syndrome): review of the literature. J Eur Acad Dermatol Venereol 2009; 23:499.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/7\" class=\"nounderline abstract_t\">Kluger N, Cribier B. [Stigmata: From Saint-Francis of Assisi to idiopathic haematidrosis]. Ann Dermatol Venereol 2013; 140:771.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/8\" class=\"nounderline abstract_t\">Zhou L, Kardous A, Weitberg A. Psychogenic purpura. Med Health R I 2001; 84:299.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/9\" class=\"nounderline abstract_t\">Klein RF, Gonen JY, Smith CM. Psychogenic purpura in a man. Psychosom Med 1975; 37:41.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/10\" class=\"nounderline abstract_t\">Bartralot R, Gonz&aacute;lez-Castro U, Repiso T, Castells Rodellas A. [Autoerythrocyte sensitization syndrome (psychogenic purpura)]. Med Clin (Barc) 1995; 105:117.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/11\" class=\"nounderline abstract_t\">Stocker WW, McIntyre OR, Clendenning WE. Psychogenic purpura. Arch Dermatol 1977; 113:606.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/12\" class=\"nounderline abstract_t\">Koblenzer PJ, Koblenzer CS. Psychogenic purpura: a most distressing case. Cutis 1990; 45:60.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/13\" class=\"nounderline abstract_t\">Lindahl MW. Psychogenic purpura: report of a case. Psychosom Med 1977; 39:358.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/14\" class=\"nounderline abstract_t\">Lozano M, Avila JJ, Denia M, Mu&ntilde;oz E. Analysis of the family structure in a case of psychogenic purpura. Gen Hosp Psychiatry 1986; 8:205.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/15\" class=\"nounderline abstract_t\">Archer-Dubon C, Orozco-Topete R, Reyes-Gutierrez E. Two cases of psychogenic purpura. Rev Invest Clin 1998; 50:145.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/16\" class=\"nounderline abstract_t\">Boussault P, Doutre MS, Beylot-Barry M, et al. [Painful bruising syndrome: a psychogenic disease]. Rev Med Interne 2005; 26:744.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/17\" class=\"nounderline abstract_t\">Behrendt C, Goos M, Thiel H, Hengge UR. [Painful bruising syndrome]. Hautarzt 2001; 52:634.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/18\" class=\"nounderline abstract_t\">Du Toit JM, Jacobs P, Bird AR, Dickson DN. Auto-erythrocyte sensitisation--the Gardner-Diamond syndrome. A case report. S Afr Med J 1989; 76:629.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/19\" class=\"nounderline abstract_t\">Struneck&aacute; A, Krpejsov&aacute; L, Palecek J, et al. Transbilayer redistribution of phosphatidylserine in erythrocytes of a patient with autoerythrocyte sensitization syndrome (psychogenic purpura). Folia Haematol Int Mag Klin Morphol Blutforsch 1990; 117:829.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/20\" class=\"nounderline abstract_t\">Frantzen E, Voigtl&auml;nder V, Gerhardt H. [Gardner-Diamond syndrome]. Hautarzt 1990; 41:168.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/21\" class=\"nounderline abstract_t\">Kossard S, McGrath M, Finley G. Localised recurrent painful bruises. Gardner-Diamond syndrome of autoerythrocyte sensitisation, psychogenic purpura. Australas J Dermatol 1993; 34:37.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/22\" class=\"nounderline abstract_t\">Kirschner MH, Hofmann GO, Markewitz A, et al. Osteosynthetic reconstruction in a patient with Gardner-Diamond syndrome. J Trauma 1995; 38:392.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/23\" class=\"nounderline abstract_t\">Moll S. Psychogenic purpura. Am J Hematol 1997; 55:146.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/24\" class=\"nounderline abstract_t\">Y&uuml;cel B, Kiziltan E, Aktan M. Dissociative identity disorder presenting with psychogenic purpura. Psychosomatics 2000; 41:279.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/25\" class=\"nounderline abstract_t\">Garypidou V, Perifanis V, Tziomalos K, et al. Gardner-Diamond syndrome. J Dermatol 2004; 31:587.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/26\" class=\"nounderline abstract_t\">Siddi GM, Montesu MA. Gardner-Diamond syndrome. J Eur Acad Dermatol Venereol 2006; 20:736.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/27\" class=\"nounderline abstract_t\">Vaidyanathan L, Vazquez JJ, Stead LG. Images in emergency medicine. Gardner-Diamond syndrome. Ann Emerg Med 2007; 50:108, 119.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/28\" class=\"nounderline abstract_t\">Durmazlar SP, Atacan D, Cemil B, Eskioglu F. Is Gardner-Diamond syndrome associated with hormonal influences along with psychosocial problems? A delayed diagnosis. Eur J Dermatol 2009; 19:259.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/29\" class=\"nounderline abstract_t\">Sotiriou E, Apalla Z, Apalla K, Panagiotidou D. Case report: psychogenic purpura. Psychosomatics 2010; 51:274.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/30\" class=\"nounderline abstract_t\">Silny W, Marciniak A, Czarnecka-Operacz M, et al. Gardner-Diamond syndrome. Int J Dermatol 2010; 49:1178.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/31\" class=\"nounderline abstract_t\">Chebbi W, Zantour B. [Painful bruising syndrome: an entity rare not to ignore]. Pan Afr Med J 2014; 17:73.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/32\" class=\"nounderline abstract_t\">Tainwala RR, Phiske M, Raghuwanshi A, et al. Perplexing purpura in two females: Rare case of autoerythrocyte sensitization syndrome. Indian Dermatol Online J 2013; 4:305.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/33\" class=\"nounderline abstract_t\">Silva GS, Nemoto P, Monzillo PH. Bloody tears, gardner-diamond syndrome, and trigemino-autonomic headache. Headache 2014; 54:153.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/34\" class=\"nounderline abstract_t\">Oh IY, Ko EJ, Li K. Autoerythrocyte sensitization syndrome presenting with general neurodermatitis. Asia Pac Allergy 2013; 3:204.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/35\" class=\"nounderline abstract_t\">Sarkar S, Ghosh SK, Bandyopadhyay D, Nath S. Psychogenic purpura. Indian J Psychiatry 2013; 55:192.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/36\" class=\"nounderline abstract_t\">Sawant NS, Singh DA. Antidepressant-induced Remission of Gardner Diamond Syndrome. Indian J Psychol Med 2012; 34:388.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/37\" class=\"nounderline abstract_t\">Edinger LK, Schwartzman RJ. Gardner-Diamond syndrome associated with complex regional pain syndrome. J Dermatol Case Rep 2013; 7:10.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/38\" class=\"nounderline abstract_t\">Alvin P. [Gardner-Diamond syndrome and psychogenic purpura. Case report of a 16-year-old adolescent]. Ann Pediatr (Paris) 1988; 35:333.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/39\" class=\"nounderline abstract_t\">Anderson JE, DeGoff W, McNamara M. Autoerythrocyte sensitization (psychogenic purpura): a case report and review of the literature. Pediatr Emerg Care 1999; 15:47.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/40\" class=\"nounderline abstract_t\">Sorensen RU, Newman AJ, Gordon EM. Psychogenic purpura in adolescent patients. Clin Pediatr (Phila) 1985; 24:700.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/41\" class=\"nounderline abstract_t\">Campbell AN, Freedman MH, McClure PD. Autoerythrocyte sensitization. J Pediatr 1983; 103:157.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/42\" class=\"nounderline abstract_t\">Puetz J, Fete T. Platelet function disorder in Gardner-Diamond syndrome: a case report and review of the literature. J Pediatr Hematol Oncol 2005; 27:323.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/43\" class=\"nounderline abstract_t\">Meeder R, Bannister S. Gardner-Diamond syndrome: Difficulties in the management of patients with unexplained medical symptoms. Paediatr Child Health 2006; 11:416.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/44\" class=\"nounderline abstract_t\">Datta S, Datta H, Kapoor S. A case of psychogenic purpura in a female child. J Indian Med Assoc 2009; 107:104.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/45\" class=\"nounderline abstract_t\">Hagemeier L, Schyma C, Zillhardt H, et al. Gardner-Diamond syndrome: a rare differential diagnosis of child abuse. Br J Dermatol 2011; 164:672.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/46\" class=\"nounderline abstract_t\">Baek JO, Jee HJ, Kim TK, Lee MG. Case of Gardner-Diamond syndrome after intramuscular stimulation. J Dermatol 2011; 38:1197.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/47\" class=\"nounderline abstract_t\">Jafferany M. Auto-erythrocyte sensitization syndrome (Gardner-Diamond syndrome) in a 15-year-old adolescent girl. Int J Dermatol 2013; 52:1284.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/48\" class=\"nounderline abstract_t\">Qamar U, Ahmad N, Farhan S. Per Oral Bleeding: Rare Presentation of Gardner-Diamond Syndrome. J Coll Physicians Surg Pak 2015; 25:465.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/49\" class=\"nounderline abstract_t\">Karaka&#351; Z, Karaman S, Avc&#305; B, et al. A disease difficult to diagnose: Gardner-Diamond syndrome accompanied by platelet dysfunction. Turk Pediatri Ars 2014; 49:250.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/50\" class=\"nounderline abstract_t\">Bostwick JM, Imig MW. Gardner-Diamond Syndrome: bruising feeling. Mayo Clin Proc 2008; 83:572.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/51\" class=\"nounderline abstract_t\">AGLE DP, RATNOFF OD. Purpura as a psychosomatic entity. A psychiatric study of autoerythrocyte sensitization. Arch Intern Med 1962; 109:685.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/52\" class=\"nounderline abstract_t\">Gundogar D, Yuksel Basak P, Baysal Akkaya V, Akarsu O. Autoerythrocyte sensitization syndrome associated with grief complications. J Dermatol 2006; 33:211.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/53\" class=\"nounderline abstract_t\">Panconesi E, Hautmann G. Stress, stigmatization and psychosomatic purpuras. Int Angiol 1995; 14:130.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/54\" class=\"nounderline abstract_t\">Holoubek JE, Holoubek AB. Blood, sweat and fear. &quot;A classification of hematidrosis&quot;. J Med 1996; 27:115.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/55\" class=\"nounderline abstract_t\">Fisher JG, Kollar EJ. Investigation of a stigmatic. South Med J 1980; 73:1461.</a></li><li class=\"breakAll\">Nickell J. Looking for a miracle: Weeping icons, relics, stigmata, visions and healing cures, Prometheus Books, Buffalo, NY 1996.</li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/57\" class=\"nounderline abstract_t\">Mason JW. The scope of psychoendocrine research. Psychosom Med 1968; 30:Suppl:565.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/58\" class=\"nounderline abstract_t\">Takada Y, Urano T, Takahashi H, et al. Effects of electric footshock and water immersion restraint stresses on fibrinolytic parameters in the plasma of rats. Thromb Res 1998; 89:107.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/59\" class=\"nounderline abstract_t\">Hata T, Kawabata A, Itoh E. Blood coagulation and fibrinolysis in SART-stressed (repeated cold-stressed) rats and drug effects on the altered hemostatic parameters. Jpn J Pharmacol 1991; 56:403.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/60\" class=\"nounderline abstract_t\">Lotti T, Benci M, Sarti MG, et al. Psychogenic purpura with abnormally increased tPA dependent cutaneous fibrinolytic activity. Int J Dermatol 1993; 32:521.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/61\" class=\"nounderline abstract_t\">Rowell NR. A painful bleeding syndrome associated with increased fibrinolytic activity. Br J Dermatol 1974; 91:591.</a></li><li class=\"breakAll\">Withlock FA. Psychosocial Aspects of Skin Disease, WB Saunders, Philadelphia 1976.</li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/63\" class=\"nounderline abstract_t\">Grossman RA. Autoerythrocyte sensitization worsened by a copper-containing IUD. Obstet Gynecol 1987; 70:526.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/64\" class=\"nounderline abstract_t\">Gomi H, Miura T. Autoerythrocyte sensitization syndrome with thrombocytosis. Dermatology 1994; 188:160.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/65\" class=\"nounderline abstract_t\">Fey MF, Beck EA. Psychogenic purpura, idiopathic thrombocytopenic purpura, and platelet dysfunction in the same patient. J Clin Psychiatry 1986; 47:386.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/66\" class=\"nounderline abstract_t\">Sudy E, Urbina F, Vasquez P. Autoerythrocyte sensitization syndrome with positive anticardiolipin antibodies. Br J Dermatol 1998; 138:367.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/67\" class=\"nounderline abstract_t\">Scott JP, Schiff DW, Githens JH. The autoerythrocyte sensitization syndrome as the primary manifestation of systemic lupus erythematosus. J Pediatr 1981; 99:598.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/68\" class=\"nounderline abstract_t\">Verstraete M. [Psychogenic hemorrhages]. Verh K Acad Geneeskd Belg 1991; 53:5.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/69\" class=\"nounderline abstract_t\">Ingen-Housz-Oro S, Viguier M, Guitera-Rovel P, et al. [Painful bruising syndrome mimicking cellulitis of the leg]. Ann Dermatol Venereol 2002; 129:1029.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/70\" class=\"nounderline abstract_t\">Karatosun V, Sato&#287;lu S, G&uuml;nal I, Alptekin K. Autoerythrocyte sensitization (Gardner-Diamond) syndrome mimicking compartment syndrome. Arch Orthop Trauma Surg 2003; 123:370.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/71\" class=\"nounderline abstract_t\">Kaufman RJ, Dorner AJ, Fass DN. von Willebrand factor elevates plasma factor VIII without induction of factor VIII messenger RNA in the liver. Blood 1999; 93:193.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/72\" class=\"nounderline abstract_t\">Weinrieb RM, Auriacombe M, Lynch KG, Lewis JD. Selective serotonin re-uptake inhibitors and the risk of bleeding. Expert Opin Drug Saf 2005; 4:337.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/73\" class=\"nounderline abstract_t\">Nelva A, Guy C, Tardy-Poncet B, et al. [Hemorrhagic syndromes related to selective serotonin reuptake inhibitor (SSRI) antidepressants. Seven case reports and review of the literature]. Rev Med Interne 2000; 21:152.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/74\" class=\"nounderline abstract_t\">Ottervanger JP, Stricker BH, Huls J, Weeda JN. Bleeding attributed to the intake of paroxetine. Am J Psychiatry 1994; 151:781.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/75\" class=\"nounderline abstract_t\">Dickinson T, Malhi S, Painter S, et al. Association between SSRIs and upper gastrointestinal bleeding. Self treatment with non-steroidal drugs may be confounding factor. BMJ 2000; 320:1406.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/76\" class=\"nounderline abstract_t\">Serebruany VL. Selective serotonin reuptake inhibitors and increased bleeding risk: are we missing something? Am J Med 2006; 119:113.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/77\" class=\"nounderline abstract_t\">Schalekamp T, Klungel OH, Souverein PC, de Boer A. Increased bleeding risk with concurrent use of selective serotonin reuptake inhibitors and coumarins. Arch Intern Med 2008; 168:180.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/78\" class=\"nounderline abstract_t\">Tielens JA. Vitamin C for paroxetine- and fluvoxamine-associated bleeding. Am J Psychiatry 1997; 154:883.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/79\" class=\"nounderline abstract_t\">Auer J, Berent R, Weber T, et al. Subarachnoid haemorrhage with &quot;Ecstasy&quot; abuse in a young adult. Neurol Sci 2002; 23:199.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/80\" class=\"nounderline abstract_t\">DAVIDSON E. FACTITIOUS PURPURA PRESENTING AS AUTOERYTHROCYTE SENSITIZATION. Br Med J 1964; 1:104.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/81\" class=\"nounderline abstract_t\">Levin RM, Chodosh R, Sherman JD. Factitious purpura simulating autoerythrocyte sensitization. Ann Intern Med 1969; 70:1201.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/82\" class=\"nounderline abstract_t\">Yates VM. Factitious purpura. Clin Exp Dermatol 1992; 17:238.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/83\" class=\"nounderline abstract_t\">ASHER R. Munchausen's syndrome. Lancet 1951; 1:339.</a></li><li><a href=\"https://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome/abstract/84\" class=\"nounderline abstract_t\">Clark GD, Key JD, Rutherford P, Bithoney WG. Munchausen's syndrome by proxy (child abuse) presenting as apparent autoerythrocyte sensitization syndrome: an unusual presentation of Polle syndrome. Pediatrics 1984; 74:1100.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 1343 Version 17.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H30\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">OVERVIEW</a><ul><li><a href=\"#H3\" id=\"outline-link-H3\">Bleeding episodes</a></li><li><a href=\"#H4\" id=\"outline-link-H4\">Concomitant psychiatric conditions</a></li><li><a href=\"#H5\" id=\"outline-link-H5\">Religious stigmata</a></li></ul></li><li><a href=\"#H6\" id=\"outline-link-H6\">PATHOPHYSIOLOGY</a><ul><li><a href=\"#H7\" id=\"outline-link-H7\">Response to stress</a></li><li><a href=\"#H8\" id=\"outline-link-H8\">Increased fibrinolysis</a></li><li><a href=\"#H9\" id=\"outline-link-H9\">Autoerythrocyte sensitization</a></li><li><a href=\"#H10\" id=\"outline-link-H10\">Other mechanisms</a></li></ul></li><li><a href=\"#H11\" id=\"outline-link-H11\">EVALUATION AND DIAGNOSIS</a><ul><li><a href=\"#H11814458\" id=\"outline-link-H11814458\">Evaluation</a><ul><li><a href=\"#H12\" id=\"outline-link-H12\">- History</a></li><li><a href=\"#H13\" id=\"outline-link-H13\">- Typical episode</a></li><li><a href=\"#H14\" id=\"outline-link-H14\">- Physical examination</a></li><li><a href=\"#H15\" id=\"outline-link-H15\">- Laboratory testing</a></li></ul></li><li><a href=\"#H11814506\" id=\"outline-link-H11814506\">Diagnosis</a></li></ul></li><li><a href=\"#H18\" id=\"outline-link-H18\">DIFFERENTIAL DIAGNOSIS</a><ul><li><a href=\"#H19\" id=\"outline-link-H19\">Inherited bleeding disorders</a><ul><li><a href=\"#H20\" id=\"outline-link-H20\">- von Willebrand disease</a></li><li><a href=\"#H21\" id=\"outline-link-H21\">- Factor XIII deficiency</a></li></ul></li><li><a href=\"#H22\" id=\"outline-link-H22\">Vascular purpuras</a></li><li><a href=\"#H23\" id=\"outline-link-H23\">Antiphospholipid syndrome</a></li><li><a href=\"#H24\" id=\"outline-link-H24\">Drug intake</a><ul><li><a href=\"#H22925964\" id=\"outline-link-H22925964\">- Antiplatelet agents and anticoagulants</a></li><li><a href=\"#H25\" id=\"outline-link-H25\">- SSRIs</a></li><li><a href=\"#H26\" id=\"outline-link-H26\">- Illicit drugs</a></li><li><a href=\"#H27\" id=\"outline-link-H27\">- Steroids</a></li></ul></li><li><a href=\"#H28\" id=\"outline-link-H28\">Psychiatric conditions and malingering</a><ul><li><a href=\"#H29\" id=\"outline-link-H29\">- Munchausen syndrome</a></li></ul></li></ul></li><li><a href=\"#H11814333\" id=\"outline-link-H11814333\">TREATMENT</a></li><li><a href=\"#H30\" id=\"outline-link-H30\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#H1685165647\" id=\"outline-link-H1685165647\">ACKNOWLEDGMENT</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"HEME/1343|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=HEME/109195\" class=\"graphic graphic_picture\">- Psychogenic purpura legs</a></li><li><a href=\"image.htm?imageKey=HEME/105524\" class=\"graphic graphic_picture\">- Psychogenic purpura</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=acquired-inhibitors-of-coagulation\" class=\"medical medical_review\">Acquired inhibitors of coagulation</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=approach-to-the-adult-patient-with-a-bleeding-diathesis\" class=\"medical medical_review\">Approach to the adult patient with a bleeding diathesis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=approach-to-the-adult-with-unexplained-thrombocytopenia\" class=\"medical medical_review\">Approach to the adult with unexplained thrombocytopenia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-hereditary-hemorrhagic-telangiectasia-osler-weber-rendu-syndrome\" class=\"medical medical_review\">Clinical manifestations and diagnosis of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-of-antiphospholipid-syndrome\" class=\"medical medical_review\">Clinical manifestations of antiphospholipid syndrome</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-presentation-and-diagnosis-of-von-willebrand-disease\" class=\"medical medical_review\">Clinical presentation and diagnosis of von Willebrand disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=congenital-and-acquired-disorders-of-platelet-function\" class=\"medical medical_review\">Congenital and acquired disorders of platelet function</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=diagnosis-of-antiphospholipid-syndrome\" class=\"medical medical_review\">Diagnosis of antiphospholipid syndrome</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=direct-oral-anticoagulants-and-parenteral-direct-thrombin-inhibitors-dosing-and-adverse-effects\" class=\"medical medical_review\">Direct oral anticoagulants and parenteral direct thrombin inhibitors: Dosing and adverse effects</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=factitious-disorder-imposed-on-self-munchausen-syndrome\" class=\"medical medical_review\">Factitious disorder imposed on self (Munchausen syndrome)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=heparin-and-lmw-heparin-dosing-and-adverse-effects\" class=\"medical medical_review\">Heparin and LMW heparin: Dosing and adverse effects</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=joint-hypermobility-syndrome\" class=\"medical medical_review\">Joint hypermobility syndrome</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=major-side-effects-of-systemic-glucocorticoids\" class=\"medical medical_review\">Major side effects of systemic glucocorticoids</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=medical-child-abuse-munchausen-syndrome-by-proxy\" class=\"medical medical_review\">Medical child abuse (Munchausen syndrome by proxy)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=osteogenesis-imperfecta-clinical-features-and-diagnosis\" class=\"medical medical_review\">Osteogenesis imperfecta: Clinical features and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-amyloidosis\" class=\"medical medical_review\">Overview of amyloidosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-personality-disorders\" class=\"medical medical_review\">Overview of personality disorders</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-water-soluble-vitamins\" class=\"medical medical_review\">Overview of water-soluble vitamins</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=rare-inherited-coagulation-disorders\" class=\"medical medical_review\">Rare inherited coagulation disorders</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=selective-serotonin-reuptake-inhibitors-pharmacology-administration-and-side-effects\" class=\"medical medical_review\">Selective serotonin reuptake inhibitors: Pharmacology, administration, and side effects</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=warfarin-and-other-vkas-dosing-and-adverse-effects\" class=\"medical medical_review\">Warfarin and other VKAs: Dosing and adverse effects</a></li></ul></div></div>","javascript":null}